1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cystic Fibrosis Lung: new trials by email Literature Review of Cystic Fibrosis Lung trials Research Report on Cystic Fibrosis Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection RSP-1502, Tobramycin inhalation solution - Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic | Phase 1 / Phase 2 | Completed | Respirion Pharmaceuticals Pty Ltd | 71 | 2024-04-01 | 2026-06-25 |
| A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Inhaled SNSP113, Inhaled Placebo - Lung Diseases, Pulmonary Disease | Phase 1 | Terminated | Synspira, Inc. | 32 | 2017-09-28 | 2018-05-25 |
Cystic Fibrosis (2) · Bronchiolitis Obliterans Syndrome (1) · Burkholderia Infections (1) · Infections (1) · Lung Diseases (1) · Mycobacterium Infections, Nontuberculous (1) · Pneumonia (1) · Pseudomonas Infections (1) · Recurrence (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Genetic Diseases, Inborn (2) · Gram-Negative Bacterial Infections (2) · Infant, Newborn, Diseases (2) · Pancreatic Diseases (2) · Actinomycetales Infections (1) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Disease Attributes (1) · Graft vs Host Disease (1)
Respirion Pharmaceuticals Pty Ltd (1) · Synspira, Inc. (1)
Australia (1) · United Kingdom (1) · United States (1)